Prevalence and molecular analysis of glucose-6-phosphate dehydrogenase deficiency in Chin State, Myanmar
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is caused by X-linked recessive disorderliness. It induces severe anemia when a patient with G6PD deficiency is exposed to oxidative stress that occurs with administration of an antimalarial drug, primaquine. The distribution of G6PD deficiency remains unknown while primaquine has been used for malaria treatment in Myanmar. This study aimed to investigate the prevalence of G6PD deficiency and its variants in Chin State, Myanmar. Among 322 participants, 18 (11 males and 7 females) demonstrated a G6PD deficiency. Orissa variant was dominant in the molecular analysis. This would be related to neighboring Indian and Bangladeshi population, in which Orissa variant was also reported as the main mutation type. The screening test for G6PD deficiency before primaquine treatment appears to be important in Myanmar.
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is caused by X-linked recessive disorderliness. It induces severe anemia when a patient with G6PD deficiency is exposed to oxidative stress that occurs with administration of an antimalarial drug, primaquine. The distribution of G6PD deficiency remains unknown while primaquine has been used for malaria treatment in Myanmar. This study aimed to investigate the prevalence of G6PD deficiency and its variants in Chin State, Myanmar. Among 322 participants, 18 (11 males and 7 females) demonstrated a G6PD deficiency. Orissa variant was dominant in the molecular analysis. This would be related to neighboring Indian and Bangladeshi population, in which Orissa variant was also reported as the main mutation type. The screening test for G6PD deficiency before primaquine treatment appears to be important in Myanmar.
참고문헌 (35)
- Cappellini MD, "Glucose-6-phosphate dehydrogenase deficiency", Lancet, 371(9606), pp.64~74 (2008)[DOI]
- Beutler E, "Glucose-6-phosphate dehydrogenase deficiency : a historical perspective", Blood, 111(1), pp.16~24 (2008)[DOI]
- Chen EY, "Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome", Genomics, 10(3), pp.792~800 (1991)[DOI]
- Chaumeau V, "Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar", J Infect Dis, 219(9), pp.1499~1509 (2019)[DOI]
- Martini G, "Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase", EMBO J, 5(8), pp.1849~1855 (1986)[DOI]
- Vulliamy TJ, "Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia", Proc Natl Acad Sci U S A, 85(14), pp.5171~5175 (1988)[DOI]
- Luzzatto L, "G6PD deficiency : a classic example of pharmacogenetics with on-going clinical implications", Br J Haematol, 164(4), pp.469~480 (2014)[DOI]
- Hirono A, "Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants", Proc Natl Acad Sci U S A, 86(24), pp.10015~10017 (1989)[DOI]
- Van Zwieten R, "Inborn defects in the antioxidant systems of human red blood cells", Free Radic Biol Med, 67, pp.377~386 (2014)[DOI]
- Beutler E, "The NT 1311 polymorphism of G6PD : G6PD Mediterranean mutation may have originated independently in Europe and Asia", Am J Hum Genet, 47(6), pp.1008~1012 (1990)
- Ahluwalia A, "G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu-->Lys mutation", Hum Mol Genet, 1(3), pp.209~210 (1992)[DOI]
- Frank JE, "Diagnosis and management of G6PD deficiency", Am Fam Physician, 72(7), pp.1277~1282 (2005)
- Matsuoka H, "Glucose-6-phosphate dehydrogenase(G6PD)mutations in Myanmar : G6PD Mahidol(487G>A)is the most common variant in the Myanmar population", J Hum Genet, 49(10), pp.544~547 (2004)[DOI]
- Nuchprayoon I, "Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar", J Hum Genet, 53, pp.48~54 (2008)[DOI]
- Li Q, "Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency at the China-Myanmar Border", PLoS One, 10(7), pp.e0134593~ (2015)[DOI]
- Lee J, "Prevalence of glucose-6-phosphate dehydrogenase(G6PD)deficiency among malaria patients in Upper Myanmar", BMC Infect Dis, 18(1), pp.131~ (2018)[DOI]
- Aung PL, "Predictors of malaria rapid diagnostic test positivity in a high burden area of Paletwa Township, Chin State in Western Myanmar", Infect Dis Poverty, 10(1), pp.6~ (2021)[DOI]
- Goo YK, "First evaluation of glucose-6-phosphate dehdrogenase(G6PD)deficiency in vivax malaria endemic regions in the Republic of Korea", PLoS One, 9(5), pp.e97390~ (2014)[DOI]
- Bancone G, "Molecular characterization and mapping of glucose-6-phosphate dehydrogenase(G6PD)mutations in the Greater Mekong Subregion", Malar J, 18(1), pp.20~ (2019)[DOI]
- Than AM, "High incidence of 3-thalassemia, hemoglobin E, and glucose-6-phosphate dehydrogenase deficiency in populations of malaria-endemic southern Shan State, Myanmar", Int J Hematol, 82(2), pp.119~123 (2005)[DOI]
- Bancone G, "Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border", PLoS One, 9(12), pp.e116063~ (2014)[DOI]
- May WL, "Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children", PLoS One, 14(1), pp.e0209204~ (2019)[DOI]
- Deng Z, "Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia", PLoS One, 12(5), pp.e0177917~ (2017)[DOI]
- Iwai K, "Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia", Hum Genet, 108(6), pp.445~449 (2001)[DOI]
- Kawamoto F, "Further molecular analysis of G6PD deficiency variants in southern Vietnam and a novel variant designated as G6PD Ho Chi Minh(173 A>G; 58 Asp>Gly) : frequency distributions of variants compared with those in other southeast Asian countries", Acta Med Okayama, 71(4), pp.325~332 (2017)[DOI]
- Kawamoto F, "Further investigations of glucose-6-phosphate dehydrogenase variants in Flores Island, eastern Indonesia", J Hum Genet, 51, pp.952~957 (2006)[DOI]
- Government of Myanmar, "The 2014 Myanmar Population and Housing Census, Chin state", Department of Popilation Ministry of Immigration and Population, ~ (2015)
- Han KT, "G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination", Trop Med Health, 49(1), pp.47~ (2021)[DOI]
- Ahluwalia A, "G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu-->Lys mutation", Hum Mol Genet, 1(3), pp.209~210 (1992)[DOI]
- Sukumar S, "Molecular basis of G6PD deficiency in India", Blood Cells Mol Dis, 33(2), pp.141~145 (2004)[DOI]
- Saker SK, "Molecular analysis of glucose-6-phosphate dehydrogenase gene mutations in Bangladeshi individuals", PLoS One, 11(11), pp.e0166977~ (2016)[DOI]
- Piomelli S, "In vivo lability of glucose-6-phosphate dehydrogenase in GdA-and GdMediterranean deficiency", J Clin Invest, 47(4), pp.940~948 (1968)[DOI]
- McCurdy PR, "A Chinese variant of glucose-6-phosphate dehydrogenase", J Lab Clin Med, 67(3), pp.374~385 (1966)
- Kaeda JS, "A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa(44 Ala-->Gly), is the major polymorphic variant in tribal populations in India", Am J Hum Genet, 57(6), pp.1335~1341 (1995)
- Boonyuen U, "Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase(G6PD)variants, G6PDViangchan and G6PDViangchan+Mahidol : Decreased stability and catalytic efficiency contribute to the clinical phenotype", Mol Genet Metab, 118(2), pp.84~91 (2016)[DOI]
